Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors.
Trio Pharmaceuticals has raised $3.1M in total funding. The most recent round was Seed. The last funding was announced in December 2024.
Trio Pharmaceuticals's investors include NuFund Venture Group, Tech Coast Angels, Myeloma Investment Fund, Life Science Angels, SeedFolio.
Trio Pharmaceuticals is headquartered in San Diego, United States.
Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors.
Trio Pharmaceuticals is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Trio Pharmaceuticals — Funding & Investors." VCBacked, December 3, 2024, https://www.vcbacked.co/company/trio-pharmaceuticals. Accessed August 1, 2026.
VCBacked. (2024). Trio Pharmaceuticals — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/trio-pharmaceuticals
{{cite web |title=Trio Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/trio-pharmaceuticals |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated